Overexpression of CD44 is associated with low expression of E-cadherin, high expression of vimentin, a high percentage of phospho-Smad2 positive nuclei and poor prognosis in hepatocellular carcinoma (HCC) patients [47]. Here, SMAD2 is linked to hepatocellular carcinoma.